BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30188953)

  • 1. Chronic obstructive pulmonary disease with short-acting inhaled pharmacotherapy increases the risk of prostate cancer: A two-stage database approach.
    Lin HW; Lin LF; Chen HC; Liou TH; Huang SW
    PLoS One; 2018; 13(9):e0203377. PubMed ID: 30188953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW; Chung CL; Lin YS; Yu CM; Lee CN; Bien MY
    PLoS One; 2015; 10(7):e0130102. PubMed ID: 26158649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
    Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and health care resource use of subjects with COPD in the year before initiating LAMA monotherapy or LAMA+LABA combination therapy: A U.S. database study.
    Nagar S; Patel J; Stanford RH
    Manag Care; 2018 May; 27(5):40-47. PubMed ID: 29763411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD.
    Liu SF; Kuo HC; Liu GH; Ho SC; Chang HC; Huang HT; Chen YM; Huang KT; Chen KY; Fang WF; Lin MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1607-14. PubMed ID: 27478374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease associated with increased risk of bipolar disorder.
    Su VY; Hu LY; Yeh CM; Chiang HL; Shen CC; Chou KT; Chen TJ; Lu T; Tzeng CH; Liu CJ
    Chron Respir Dis; 2017 May; 14(2):151-160. PubMed ID: 28528563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease.
    Amin AN; Bollu V; Stensland MD; Netzer L; Ganapathy V
    Am J Health Syst Pharm; 2018 Mar; 75(6):359-366. PubMed ID: 29523532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
    Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does chronic obstructive pulmonary disease increase the risk of prostate cancer? A nationwide population-based study.
    Hsu WL; Chen HY; Chang FW; Hsu RJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1913-1921. PubMed ID: 31686802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids in COPD and the risk of lung cancer.
    Lee YM; Kim SJ; Lee JH; Ha E
    Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
    Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of guideline-based therapy for chronic obstructive pulmonary disease: Differences between men and women veterans.
    Rinne ST; Elwy AR; Liu CF; Wiener RS; Thayer L; Gerity A; Bastian LA
    Chron Respir Dis; 2017 Nov; 14(4):385-391. PubMed ID: 28618875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
    Lei YF; Lin HC; Lin HL; Uang YS; Cheng HW; Wang LH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2573-2581. PubMed ID: 33116474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.